India to Cut Trial Approval Times by Early Next Year

Posted 19 December 2011 | By

Regulatory changes in India have contributed to lengthening and inconsistency in the time taken to have trial approved. The uncertainty has challenged contract research organizations, but, according to the Drug Controller General of India, this situation is expected to improve shortly. The latest of the changes is the draft guidance on clinical trial compensation. (Outsourcing Pharma)


Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Most Viewed Articles